Cart
0

Sleep Apnea Diagnostics Market by Product (Polysomnography (PSG) Device, Actigraphy System, Respiratory Polygraph, Sleep Apnea Screening Device, and Oximeter) and End User (Hospitals & Sleep Laboratories and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

Get 20% Free Customization In This Report
LI_184666
Pages: 180
Dec 2018 | 724 Views
 
Author(s) : Onkar Sumant, Tenzin Kunsel, Kavita Joshi
Tables: 83
Charts: 34
 

Sleep Apnea Diagnostics Market Overview:

The global sleep apnea diagnostics market was valued at $99 million in 2017, and is expected to reach $168 million by 2025, registering a CAGR of 6.8% from 2018 to 2025.

Sleep apnea or sleep disordered breathing (SDB) is a potentially serious sleep disorder where breathing stops and starts repeatedly. It occurs when the upper airway gets blocked frequently while sleeping, thereby, reducing the airflow. This condition is known as obstructive sleep apnea (OSA). If the brain does not send the signals needed to breathe, the condition is referred to as central sleep apnea. Around 85% to 90% of OSA patients are estimated to remain undiagnosed, which demonstrates the unmet medical need. The sleep apnea diagnostic products evaluate patient’s breathing and other body functions during sleep, thereby boosting the demand for these devices to combat sleep apnea disease worldwide.

Get more information on this report : Request Sample Pages

Increase in geriatric population; growth in sedentary lifestyle diseases such as obesity, diabetes, and others; and significant rise in awareness regarding sleep apnea drive the growth of the market. In addition, technological advancements to make products more comfortable for patients and considerable upsurge in sleep apnea disorders boost the growth of the global market. However, expensive tools used for the treatment of sleep apnea, limited reimbursement of these devices, and low patient compliance are projected to hinder the market growth. Moreover, gradual increase in preference for home healthcare devices is projected to offer lucrative growth opportunities in the near future.


Get more information on this report : Request Sample Pages

Based on product, the sleep apnea diagnostics market is segmented into polysomnography (PSG) device, actigraphy system, respiratory polygraph, sleep apnea screening device, and oximeter. The PSG device segment was the highest contributor to the market in 2017 and is anticipated to maintain its dominance throughout the forecast period. This was attributed to the fact that it is a multi-parameter study that records patient’s brain waves, the oxygen level in your blood, heart rate and breathing, and even eye and leg movements during the diagnosis procedure.

Get more information on this report : Request Sample Pages

Based on end user, the sleep apnea diagnostics market is classified into hospitals & sleep laboratories and home care settings. The hospitals & sleep laboratories segment accounted for the highest revenue in 2017 and is expected to maintain its dominance throughout the forecast period. This is attributed to the preference among patients to visit hospitals & sleep laboratories for the diagnosis of sleep apnea. In addition, hospitals & sleep laboratories are well equipped with all the diagnosis equipment that can help detect sleep problems by monitoring brain activity, eye movement, heart rate, snoring, body movements, and more.

Get more information on this report : Request Sample Pages

Based on region, the sleep apnea diagnostics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America dominated the market in 2017, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to the rise in incidence of sleep apnea and government initiatives toward growing awareness among patients regarding the same. However, Asia-Pacific is projected to register the highest growth rate from 2018 to 2025.

The report provides a comprehensive analysis of the leading companies operating in the global market such as Cadwell Laboratories Inc., DeVilbiss Healthcare LLC., Koninklijke Philips N.V., Medtronic plc, Mindray, Natus Medical Incorporated, Nihon Kohden Corporation, Resmed, Smiths Medical, and SomnoMedics.

The other key players operating in the market include Cleveland Medical Devices, Inc., Compumedics Ltd., Fisher & Paykel Healthcare Limited, Vyaire Medical, Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., and others.

Key Benefits for Sleep Apnea Diagnostics Market:

  • The study provides an in-depth analysis of the global sleep apnea diagnostics market along with the current trends and future estimations to elucidate the imminent investment pockets.

  • A comprehensive analysis of the factors that drive and restrict the market growth is provided.

  • A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.

  • An extensive analysis of the key segments of the industry helps understand the trends in the global sleep apnea diagnostics market.

  • Key players and their strategies are provided to understand the competitive outlook of the industry.

Sleep Apnea Diagnostics Key Market Segments:

By Product

  • Polysomnography Device (PSG)

    • Clinical PSG Device

    • Ambulatory PSG Device

  • Sleep Apnea Screening Device

  • Actigraphy Monitoring Device

  • Respiratory Polygraph

  • Oximeter

  • Finger Tip Oximeter

    • Handheld Oximeter

    • Wrist-worn Oximeter

    • Tabletop Oximeter

  • Others

By End User

  • Hospitals & Sleep Laboratories

  • Home Care Settings

By Region

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • France

    • Germany

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • LAMEA

    • Saudi Arabia

    • South Africa

    • Brazil

    • Rest of LAMEA

 

Chapter: 1:    INTRODUCTION

1.1.    Report description
1.2.    Key benefits for stakeholders
1.3.    Key market segments
1.4.    Research methodology

1.4.1.    Secondary research
1.4.2.    Primary research
1.4.3.    Analyst tools & models

Chapter: 2:    EXECUTIVE SUMMARY

2.1.    CXO perspective

Chapter: 3:    MARKET OVERVIEW

3.1.    Market definition and scope
3.2.    Key findings

3.2.1.    Top investment pockets

3.3.    Top player positioning, 2017
3.4.    Market dynamics

3.4.1.    Drivers

3.4.1.1.    Rise in prevalence of obesity across the globe
3.4.1.2.    Increase in number of employees working in shifts and under stressful work conditions
3.4.1.3.    Technological advancements in sleep apnea diagnostic devices

3.4.2.    Restraints

3.4.2.1.    High cost associated with the sleep apnea diagnostic devices
3.4.2.2.    Lack of awareness among patients regarding sleep apnea

3.4.3.    Opportunity

3.4.3.1.    Untapped markets in developing economies

Chapter: 4:    SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT

4.1.    Overview

4.1.1.    Market size and forecast

4.2.    Polysomnography device (PSG)

4.2.1.    Key trends and opportunities
4.2.2.    List of Distributors
4.2.3.    Market size and forecast
4.2.4.    Market analysis, by country

4.2.4.1.    Clinical PSG Device
4.2.4.2.    Market size and forecast
4.2.4.3.    Ambulators PSG Device
4.2.4.4.    Market size and forecast

4.3.    Sleep apnea screening device

4.3.1.    Key trends and opportunities
4.3.2.    List of ditributors
4.3.3.    Market size and forecast
4.3.4.    Market analysis, by country

4.4.    Actigraphy monitoring device

4.4.1.    Key trends and opportunities
4.4.2.    List of distributors
4.4.3.    Market size and forecast
4.4.4.    Market analysis, by country

4.5.    Respiratory polygraph

4.5.1.    Key trends and opportunities
4.5.2.    List of distributors
4.5.3.    Market size and forecast
4.5.4.    Market analysis, by country

4.6.    Oximeter

4.6.1.    Key trends and opportunities
4.6.2.    List of distributors
4.6.3.    Market size and forecast
4.6.4.    Market analysis, by country
4.6.5.    Finger Tip Oximeter

4.6.5.1.    Market size and forecast

4.6.6.    Handheld Oximeter

4.6.6.1.    Market size and forecast

4.6.7.    Wrist-worn Oximeter

4.6.7.1.    Market size and forecast

4.6.8.    Tabletop Oximeter

4.6.8.1.    Market size and forecast

Chapter: 5:    SLEEP APNEA DIAGNOSTICS MARKET, BY END USER

5.1.    Overview

5.1.1.    Market size and forecast

5.2.    Hospitals & sleep laboratories

5.2.1.    List of distributors
5.2.2.    Market size and forecast
5.2.3.    Market analysis, by country

5.3.    Home care settings

5.3.1.    List of distributors
5.3.2.    Market size and forecast
5.3.3.    Market analysis, by country

Chapter: 6:    SLEEP APNEA DIAGNOSTICS MARKET, BY REGION

6.1.    Overview

6.1.1.    Market size and forecast

6.2.    North America

6.2.1.    Key trends and opportunities
6.2.2.    List of distributors
6.2.3.    North America market size and forecast, by country

6.2.3.1.    U.S. market size and forecast, by product
6.2.3.2.    U.S. market size and forecast, by end user
6.2.3.3.    Canada market size and forecast, by product
6.2.3.4.    Canada market size and forecast, by end user
6.2.3.5.    Mexico market size and forecast, by product
6.2.3.6.    Mexico market size and forecast, by end user

6.2.4.    North America market size and forecast, by product
6.2.5.    North America market size and forecast, by end user

6.3.    Europe

6.3.1.    Key trends and opportunities
6.3.2.    List of distributors
6.3.3.    Europe market size and forecast, by country

6.3.3.1.    Germany market size and forecast, by product
6.3.3.2.    Germany market size and forecast, by end user
6.3.3.3.    UK market size and forecast, by product
6.3.3.4.    UK market size and forecast, by end user
6.3.3.5.    France market size and forecast, by product
6.3.3.6.    France market size and forecast, by end user
6.3.3.7.    Italy market size and forecast, by product
6.3.3.8.    Italy market size and forecast, by end user
6.3.3.9.    Spain market size and forecast, by product
6.3.3.10.    Spain market size and forecast, by end user
6.3.3.11.    Rest of Europe market size and forecast, by Product
6.3.3.12.    Rest of Europe market size and forecast, by end user

6.3.4.    Europe market size and forecast, by product
6.3.5.    Europe market size and forecast, by end user

6.4.    Asia-Pacific

6.4.1.    Key trends and opportunities
6.4.2.    List of distributors
6.4.3.    Asia-Pacific market size and forecast, by country

6.4.3.1.    Japan market size and forecast, by product
6.4.3.2.    Japan market size and forecast, by end user
6.4.3.3.    China market size and forecast, by product
6.4.3.4.    China market size and forecast, by end user
6.4.3.5.    India market size and forecast, by product
6.4.3.6.    India market size and forecast, by end user
6.4.3.7.    Australia market size and forecast, by product
6.4.3.8.    Australia market size and forecast, by end user
6.4.3.9.    Rest of Asia-Pacific market size and forecast, by product
6.4.3.10.    Rest of Asia-Pacific market size and forecast, by end user

6.4.4.    Asia-Pacific market size and forecast, by product
6.4.5.    Asia-Pacific market size and forecast, by end user

6.5.    LAMEA

6.5.1.    Key market trends and opportunities
6.5.2.    List of distributors
6.5.3.    LAMEA market size and forecast, by country

6.5.3.1.    Brazil market size and forecast, by product
6.5.3.2.    Brazil market size and forecast, by end user
6.5.3.3.    South Africa market size and forecast, by product
6.5.3.4.    South Africa market size and forecast, by end user
6.5.3.5.    Saudi Arabia market size and forecast, by product
6.5.3.6.    Saudi Arabia market size and forecast, by end user
6.5.3.7.    Rest of LAMEA market size and forecast, by product
6.5.3.8.    Rest of LAMEA market size and forecast, by end user

6.5.4.    LAMEA market size and forecast, by product
6.5.5.    LAMEA market size and forecast, by end user

Chapter: 7:    COMPANY PROFILES

7.1.    CADWELL INDUSTRIES INC.

7.1.1.    Company overview
7.1.2.    Company snapshot
7.1.3.    Operating business segments
7.1.4.    Product portfolio

7.2.    DEVILBISS HEALTHCARE

7.2.1.    Company overview
7.2.2.    Company snapshot
7.2.3.    Operating business segments
7.2.4.    Product portfolio

7.3.    KONINKLIJKE PHILIPS N.V. (PHILIPS)

7.3.1.    Company overview
7.3.2.    Company snapshot
7.3.3.    Operating business segments
7.3.4.    Product portfolio
7.3.5.    Business performance
7.3.6.    Key Strategic Moves:

7.4.    MEDTRONIC PLC.

7.4.1.    Company overview
7.4.2.    Company snapshot
7.4.3.    Operating business segment
7.4.4.    Product portfolio
7.4.5.    Business performance

7.5.    MINDRAY MEDICAL INTERNATIONAL LIMITED

7.5.1.    Company overview
7.5.2.    Operating business segment

7.6.    NATUS MEDICAL INCORPORATED

7.6.1.    Company overview
7.6.2.    Company snapshot
7.6.3.    Product portfolio
7.6.4.    Operating business segments
7.6.5.    Business performance

7.7.    NIHON KOHDEN CORPORATION

7.7.1.    Company overview
7.7.2.    Company snapshot
7.7.3.    Operating business segments
7.7.4.    Product portfolio
7.7.5.    Business performance

7.8.    RESMED INC.

7.8.1.    Company overview
7.8.2.    Company snapshot
7.8.3.    Operating business segment
7.8.4.    Product portfolio
7.8.5.    Business performance

7.9.    SMITHS GROUP PLC. (SMITHS MEDICAL)

7.9.1.    Company overview
7.9.2.    Company snapshot
7.9.3.    Operating business segments
7.9.4.    Product portfolio
7.9.5.    Business performance
7.9.6.    Key Strategic Moves:

7.10.    SOMNOMEDICS GmbH

7.10.1.    Company overview
7.10.2.    Company snapshot
7.10.3.    Operating business segments
7.10.4.    Product portfolio

LIST OF TABLES

TABLE 01.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 02.    SLEEP APNEA DIAGNOSTICS MARKET, FOR POLYSOMNOGRAPHY DEVICE (PSG) BY REGION, 2017–2025 ($MILLION)
TABLE 03.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY REGION, 2017–2025 ($MILLION)
TABLE 04.    SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY REGION, 2017–2025 ($MILLION)
TABLE 05.    GLOBAL OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPHS, BY REGION, 2017–2025 ($MILLION)
TABLE 06.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY REGION, 2017–2025 ($MILLION)
TABLE 07.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 08.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, FOR HOSPITALS & SLEEP LABORATORIES, BY REGION 2017–2025 ($MILLION)
TABLE 09.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET, FOR HOME CARE SETTINGS, BY REGION, 2017–2025 ($MILLION)
TABLE 10.    SLEEP APNEA DIAGNOSTICS MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 11.    NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 12.    U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 13.    U.S. SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 14.    CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 15.    CANADA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 16.    MEXICO. SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 17.    MEXICO SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 18.    NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 19.    NORTH AMERICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 20.    EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 21.    GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 22.    GERMANY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 23.    UK SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 24.    UK SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 25.    FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 26.    FRANCE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 27.    ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 28.    ITALY SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 29.    SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 30.    SPAIN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 31.    REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 32.    REST OF EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 33.    EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 34.    EUROPE SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 35.    ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 36.    JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 37.    JAPAN SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 38.    CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 39.    CHINA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 40.    INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 41.    INDIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 42.    AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 43.    AUSTRALIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 44.    REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 45.    REST OF ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 46.    ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 47.    ASIA-PACIFIC SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48.    LAMEA ALLERY END USER MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 49.    BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 50.    BRAZIL SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 51.    SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 52.    SOUTH AFRICA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 53.    SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 54.    SAUDI ARABIA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 55.    REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 56.    REST OF LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 57.    LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY PRODUCT, 2017–2025 ($MILLION)
TABLE 58.    LAMEA SLEEP APNEA DIAGNOSTICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 59.    CADWELL: COMPANY SNAPSHOT
TABLE 60.    CADWELL: OPERATING SEGMENTS
TABLE 61.    CADWELL: PRODUCT PORTFOLIO
TABLE 62.    DEVILBISS: COMPANY SNAPSHOT
TABLE 63.    DEVILBISS: PRODUCT PORTFOLIO
TABLE 64.    PHILIPS: COMPANY SNAPSHOT
TABLE 65.    PHILIPS: OPERATING SEGMENTS
TABLE 66.    PHILIPS: PRODUCT PORTFOLIO
TABLE 67.    MEDTRONIC: COMPANY SNAPSHOT
TABLE 68.    MEDTRONIC: OPERATING SEGMENT
TABLE 69.    MEDTRONIC: PRODUCT PORTFOLIO
TABLE 70.    MINDRAY: COMPANY SNAPSHOT
TABLE 71.    MINDRAY: OPERATING SEGMENTS
TABLE 72.    NATUS: COMPANY SNAPSHOT
TABLE 73.    NATUS: PRODUCT PORTFOLIO
TABLE 74.    NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 75.    NIHON KOHDEN: OPERATING SEGMENTS
TABLE 76.    NIHON: PRODUCT PORTFOLIO
TABLE 77.    RESMED: COMPANY SNAPSHOT
TABLE 78.    RESMED: PRODUCT PORTFOLIO
TABLE 79.    SMITHS: COMPANY SNAPSHOT
TABLE 80.    SMITHS: OPERATING SEGMENTS
TABLE 81.    SMITHS: PRODUCT PORTFOLIO
TABLE 82.    SOMNOMEDICS: COMPANY SNAPSHOT
TABLE 83.    SOMNOMEDICS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.    SLEEP APNEA DIAGNOSTIC DEVICES MARKET SEGMENTATION
FIGURE 02.    TOP INVESTMENT POCKETS
FIGURE 03.    TOP PLAYER POSITIONING, 2017
FIGURE 04.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 05.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKETFOR POLYSOMNOGRAPHY DEVICE (PSG) BY COUNTRY, 2017 & 2025 (%)
FIGURE 06.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR CLINICAL PSG DEVICE, 2017–2025 ($MILLION)
FIGURE 07.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR ABULATORS PSG DEVICE, 2017–2025 ($MILLION)
FIGURE 08.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR SLEEP APNEA SCREENING DEVICE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 09.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR ACTIGRAPHY MONITORING DEVICE, BY COUNTRY, 2017 & 2025 (%)
FIGURE 10.    COMPARATIVE SHARE ANALYSIS OF OTHER SLEEP APNEA DIAGNOSTICS MARKET FOR RESPIRATORY POLYGRAPH, BY COUNTRY, 2017 & 2025 (%)
FIGURE 11.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR OXIMETER, BY COUNTRY,  2017 & 2025 (%)
FIGURE 12.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR FINGER TIP OXIMETER, 2017–2025 ($MILLION)
FIGURE 13.    GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR HANDHELD OXIMETER, 2017–2025 ($MILLION)
FIGURE 14.    MARKET SIZE AND FORECAST GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR WRIST WORN OXIMETER, 2017–2025 ($MILLION)
FIGURE 15.    MARKET SIZE AND FORECAST GLOBAL SLEEP APNEA DIAGNOSTICS MARKET FOR TABLE TOP OXIMETER, 2017–2025 ($MILLION)
FIGURE 16.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET, FOR RETAIL PHARMACIES,  BY COUNTRY, 2017 & 2025 (%)
FIGURE 17.    COMPARATIVE SHARE ANALYSIS OF SLEEP APNEA DIAGNOSTICS MARKET FOR HOME CARE SETTINGS,  BY COUNTRY 2017 & 2025 (%)
FIGURE 18.    PHILIPS: NET SALES, 2015–2017 ($MILLION)
FIGURE 19.    PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 20.    PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 21.    MEDTRONIC: NET SALES, 2015–2017 ($MILLION)
FIGURE 22.    MEDTRONIC: REVENUE SHARE PER SEGMENT 2017(%)
FIGURE 23.    MEDTRONIC: REVENUE SHARE BY REGION 2017(%)
FIGURE 24.    NATUS: NET SALES, 2015–2017 ($MILLION)
FIGURE 25.    NATUS: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 26.    NATUS: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 27.    NIHON KOHDEN: NET SALES, 2015–2017 ($MILLION)
FIGURE 28.    NIHON KOHDEN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29.    NIHON KOHDEN: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 30.    RESMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 31.    RESMED: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 32.    SMITHS: NET SALES, 2015–2017 ($MILLION)
FIGURE 33.    SMITHS: REVENUE SHARE BY DIVISION, 2017 (%)
FIGURE 34.    SMITHS: REVENUE SHARE BY REGION, 2017 (%)

 

Sleep apnea is a condition in which the patient suffers from regularly interrupted sleep that can have a big impact on quality of life and increases the risk of developing certain conditions. The most prevalent symptoms of sleep apnea include loud snoring, noisy and labored breathing, repeated short periods where breathing is interrupted by gasping or snorting, and others. Sleep apnea has become one of the major health concerns globally.

The sleep apnea diagnostics market gained the interest of the healthcare industry due to a significant increase in the incidence of sedentary lifestyle disorders including obesity, diabetes, hypertension, and others. These diseases are one of the major causes that led to sleep apnea. In addition, working in shifts and stressful working environments also is a cause of sleep apnea.

Among all the products used for the diagnosis of sleep apnea, polysomnography device (PSG) is the most widely used product, owing to the accuracy of the data it offers and also measures different parameters required for the diagnosis of sleep apnea such as brain monitoring, eye movement, and others. However, the actigraphy monitoring devices market is predicted to grow at a fast pace due to the shift in preferences among patients for home care devices.

North America accounted for the highest market share and is estimated to continue the same during the forecast period. This is attributed to the presence of better medical facilities and ease of availability of the medical devices required for the diagnosis of sleep apnea. However, Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period due to significant rise in sedentary lifestyle disorders including obesity, hypertension, and others. As obesity is one of the major factors leading to cause sleep apnea, thereby, increase in obesity prevalence in Asia-Pacific is anticipated to contribute to the market growth in this region. Further, the sleep apnea diagnostics market is expected to witness a substantial growth due to the significant rise in the sleep apnea across the globe.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Download Sample

Request Customization

Download sample

OR

Purchase Full Report of
Sleep Apnea Diagnostics Market

  • Online Only
  • $3456
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 
Download Sample

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo